Biosimilars Australia in Canberra, Australian Capital Territory | Medical and health

Biosimilars Australia

Locality: Canberra, Australian Capital Territory

Address: PO Box 87, Deakin West 2600 Canberra, ACT, Australia

Website: https://www.biosimilarhub.com.au/

Likes: 1471

Add/Update information

Reviews

Tags

• Medical and health

25.01.2022 Did you know? Medicines have been developed since around 3,000 BC? Ancient artefacts mention using willow leaves to treat pain. If you're interested in learning more about biosimilar medicines and their development journey, visit the Biosimilar Hub to view an interactive timeline taking you from early stage medicines development to the new era of modern medicine. Find out more here: https://biosimilarhub.com.au//history-of-biological-medic/

25.01.2022 With lower treatment costs thanks to #biosimilars, we can re-invest in other health care services - like childcare, eldercare, mental health services, research and more. In addition, by lowering treatment costs, biosimilars can help fund the innovative new treatments needed by patients. To learn more about how biosimilar medicines can contribute to the future sustainability of the Australian healthcare system, visit: biosimilarhub.com.au #GlobalBiosimilarsWeek ... For an international perspective visit the #GlobalBiosimilarsWeek website: https://lnkd.in/g6qs2ak

24.01.2022 Have you tested out your knowledge of biological, including biosimilar, medicines? Build upon your understanding of what makes biological medicines unique and how biosimilar brands can benefit Australia's healthcare system. Challenge yourself in GBMA's Educational interactive learning experience on the Biosimilar Hub and start your biosimilar medicines journey today! Find out more: https://biosimilarhub.com.au/consumer/interactive-question/

24.01.2022 From all of us here at GBMA Education we wish you and your family a happy and safe holiday season. After a challenging year for everyone - we hope that you get some time to relax with loved ones and look forward to the new year ahead. We look forward to continuing to support healthcare professionals and consumers and sharing more about biosimilar medicines in the new year! As always the Biosimilar Hub hosts a multitude of resources to support biosimilar medicine education an...d is always available if you want to learn more. To sign up for updates on the latest biosimilar news, visit the Biosimilar Hub: https://biosimilarhub.com.au/consumer/stay-in-touch/

24.01.2022 Did you know? Factsheets and brochures are available to download across 8 languages to help support discussions with your healthcare professional or friends and family about biosimilar medicines. Visit the Biosimilar Hub to find out more: https://biosimilarhub.com.au/consumer/essentials-factsheets/

23.01.2022 Do you have questions about biosimilar medicines? GBMA Education is pleased to announce an upcoming Q&A series, where we will call on the advice of Australian specialists to answer your questions. Submit your questions here and stay tuned.

19.01.2022 Greater access to #biosimilars = more care for more patients. #Biosimilars are the key to building a better future for patients around the globe. In order to provide more patients with more care, we need policies that support greater access to biosimilar medicines. Join us in celebrating #GlobalBiosimilarsWeek and learn more about how biosimilar medicines can contribute to the future sustainability of the Australian healthcare system, visit: biosimilarhub.com.au... To learn more about the international experience, visit the #GlobalBiosimilarsWeek website: https://lnkd.in/g6qs2ak

18.01.2022 Did you know? In Australia, the safety and effectiveness of all biological medicines, including biosimilar medicines, are upheld to the high standards of the Therapeutic Goods Administration (TGA). For more information on biosimilar medicines, visit the Biosimilar Hub: https://biosimilarhub.com.au/consumer/

17.01.2022 In the second instalment of our patient video series we hear from Rheumatologist, Professor Michelle Leech, who answers common questions that their patients have about #biosimilarmedicines. To view the video in full visit: https://biosimilarhub.com.au//biosimilar-medicines-in-aus/

16.01.2022 As 2020 draws to a close we are going to be looking back on some of our favourite #biosimilarmoments2020 of the year. One standout moment was celebrating our second Biosimilar Awareness Week earlier in May, kicked off by the Hon. Greg Hunt, Minister for Health, and inviting all consumers and carers to get involved and join in the conversation about the importance of biosimilar medicines. With your support - we managed to make over 500,000 Australians across the country aware... of the role they can play in supporting the future of a sustainable healthcare system. #BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

16.01.2022 #GlobalBiosimilarsWeek is officially here - an initiative that we are pleased to support - which aims to increase awareness and knowledge of biosimilar medicines worldwide! Each day this week we will be focusing on a different topic related to biosimilar medicines. Today we are focusing on 'Biosimilar Basics'... A biosimilar medicine is a highly similar version of an original brand of a biological medicine, marketed by a different manufacturer once the patent on the original brand expires. Brands of the same biological medicine, including biosimilar brands, are used to effectively treat diseases like cancer, diabetes and rheumatoid arthritis, in the same way. If you'd like to learn more about biosimilar medicines - head to the Biosimilar Hub for a host of engaging resources: biosimilarhub.com.au/consumer/ If you would like to find out more about the international initiative, visit the official Global Biosimilars Week website https://bit.ly/IGBAGBW #GlobalBiosimilarsWeek #BiosimilarsAwareness

15.01.2022 #Biosimilars: the future of sustainable healthcare. The continued development of #biosimilar medicines, coupled with policies that promote biosimilars education and adoption, will encourage health equity and access to care for millions of patients worldwide. This #GlobalBiosimilarsWeek, join us in looking at the road ahead for the #biosimilars industry.... Visit the Biosimilar Hub to learn more about how biosimilar medicines can contribute to the future sustainability of the Australian healthcare system, visit: biosimilarhub.com.au To learn more about the international experience, visit the #GlobalBiosimilarsWeek website: https://lnkd.in/g6qs2ak

15.01.2022 This month we're continuing to share some favourite #biosimilarmoments2020 from the past year! Today we're looking at our market research report which was released just last month. The report was very encouraging and noted a significant increase in confidence and usage of biosimilar medicines since 2016. Some key facts and findings from the report:... - Community pharmacist experience with biosimilar medicines has increased dramatically by 77% - GPs reported a 56% increase in reported familiarity with biosimilar medicines - Consumers and carers reported a 12.5% increase in confidence in taking biosimilar medicines To read more insights from GBMA Education's Market Research Report, visit the Biosimilar Hub: https://bit.ly/2IqNj1h #BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

15.01.2022 Today marks Day 4 of #GlobalBiosimilarsWeek. Did you know? Biosimilar brands of biological medicines have been safely used in Australia since 2010. Since then, there are now 18 biosimilar brands available on the Pharmaceutical Benefits Scheme (PBS), representing 9 original biological brands To learn more about which biosimilar brands are subsidised on the Pharmaceutical Benefits Scheme in Australia, visit the Biosimilar Hub: https://biosimilarhub.com.au/biosimilar-medicines.../ Overseas they have over two billion days of patient experience with biosimilar medicines. To learn more about the international experience, visit the #GlobalBiosimilarsWeek website: https://bit.ly/IGBAGBW #BiosimilarsAwareness

15.01.2022 What are the benefits of using biosimilar medicines? Biosimilar brands of biological medicines are used to effectively treat the same conditions in the same way. The benefit of using biosimilar medicines is that they encourage competition in the market which can reduce price for the Australian Government. This allows resources to be reallocated to help fund other health initiatives and allows more medicines to be covered by the PBS, helping to contribute to a more sustainabl...e Australian healthcare system. Visit the Biosimilar Hub to find out more www.biosimilarhub.com.au/consumer/

14.01.2022 It's Day 3 of Global Biosimilars Week and today we are discussing the benefits of biosimilar medicines: Biosimilar brands of biological medicines are used to effectively treat the same conditions in the same way. The introduction of biosimilar medicines encourages brand competition in the Australian market. This can improve the Government’s capacity to fund expanded access to biological medicines as they become more affordable, and reduce the risk of medicine shortages.... To find out more how biosimilar medicines can contribute to the future sustainability of the Australian healthcare system, visit: biosimilarhub.com.au Biosimilar medicines help health systems around the world. For an international perspective visit the #GlobalBiosimilarsWeek website: https://bit.ly/IGBAGBW #TrustBiosimilars

13.01.2022 Did you know? Since the first approval of a biosimilar medicine, around 15 years of experience has found no difference in the safety or health of patients using a biosimilar medicine. Biosimilar medicines have helped improve the lives of thousands of Australians with serious illnesses such as cancer, rheumatoid arthritis, inflammatory bowel disease, severe psoriasis, multiple sclerosis and kidney disease.... For more detailed information on biosimilar medicines, our factsheets and brochures are available to download across 8 languages to help support discussions with your healthcare professional or friends and family. Visit to the Biosimilar Hub to find out more: https://biosimilarhub.com.au/consumer/essentials-factsheets/

12.01.2022 Did you know? Biosimilar brands of biological medicines are used to treat the same diseases, at the same dose and in the same way as the original brand of a biological medicine All biological medicines, including biosimilar medicines, are thoroughly tested by the Therapeutic Goods Administration (TGA) to ensure they meet the same strict standards for quality, safety and effectiveness. These rigorous quality control processes ensure that people will experience the same safety ...and effectiveness from their biological medicine, whether they receive the original (reference) brand or the biosimilar brand. For more information on biosimilar medicines, visit the Biosimilar Hub: https://biosimilarhub.com.au/consumer/

11.01.2022 We're pleased to share that we now have over 2,000 followers across all of our Biosimilars Australia social channels! We wanted to take this opportunity to thank you for your ongoing support, and we look forward to continuing to share more about biosimilar medicines and the benefits they have in ensuring the sustainability of our healthcare system. #BiosimilarMedicines #AustralianHealthcare #HealthcareProfessionals

11.01.2022 Did you know that most consumers in Germany are already using biosimilar medicines? Gastroenterologist Dr Simon Ghaly explains that biosimilars in Germany are just part of practice and second nature, that its not thought twice of. Biosimilar brands of biological medicines are used to effectively treat the same conditions in the same way. GBMA Education are excited to help Australian consumers better understand biosimilar medicines and their benefits through the Biosimilar H...ub. Learn more: https://biosimilarhub.com.au/consumer/

10.01.2022 GBMA Education is excited to share the first instalment from our patient video series which features experts from different specialty areas answering a range of your questions and concerns about #biosimilarmedicines. In the first instalment, Endocrinologist Professor Steven Boyages answers common questions they receive from their patients about biosimilar medicines. Professor Boyages is a diabetes specialist and shares useful information about biosimilar brands of insulin. Watch Professor Boyages break down here: https://biosimilarhub.com.au//biosimilar-medicines-in-aus/

05.01.2022 Did you know medicines have been developed since around 3,000 BC? Ancient artefacts mention using willow leaves to treat pain. If you're interested in learning more about biosimilar medicines and their development journey, visit the Biosimilar Hub to view an interactive timeline taking you from early stage medicines development to the new era of modern medicine.... Find out more here: https://biosimilarhub.com.au/.../history-of-biological.../

03.01.2022 Although #GlobalBiosimilarsWeek may be drawing to a close - it doesn’t mean that the learning stops there! We look forward to continuing to support healthcare professionals and patients to learn more about biosimilar medicines. The Biosimilar Hub is divided into two sections, one for consumers and the other for healthcare professionals, and contains a multitude of resources to support biosimilar medicine education. To sign up for updates on the latest biosimilar news, visit the Biosimilar Hub: https://biosimilarhub.com.au/consumer/stay-in-touch/

02.01.2022 Welcome to Day 2 of Global Biosimilars Week! Today we will be looking at the regulation process of biosimilar medicines. Did you know? In Australia, the Therapeutic Goods Association (TGA) ensures that all brands of the same biological medicine, including biosimilar medicines: - work in exactly the same way - treat the same illnesses... - are administered in the same way, and on the same schedule - have the same safety and efficacy If you'd like more information about biosimilar medicines - head to the Biosimilar Hub for a host of engaging resources: biosimilarhub.com.au Regulatory authorities around the world have approved #biosimilar brands as safe & effective treatments. For international information, visit the #GlobalBiosimilarsWeek website: https://bit.ly/IGBAGBW

02.01.2022 It's #GlobalBiosimilarsWeek and #biosimilars have come a long way! Safe & effective #biosimilars have been available for over 15 years. As we see more biosimilar approvals around the world, we will also see billions in savings for patients and the health care system. Visit the Biosimilar Hub to learn more about how biosimilar medicines can contribute to the future sustainability of the Australian healthcare system, visit: biosimilarhub.com.au... For an international perspective visit the #GlobalBiosimilarsWeek website: https://lnkd.in/g6qs2ak